New leadership at European PCI association
This article was originally published in Clinica
Professor Carlo Di Mario has been elected president of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), part of the European Society of Cardiology (ESC), at the end of this month. He formally replaces William Wijns on August 31, during the two-year-old association's general assembly. EAPCI, in collaboration with European medtech industry association Eucomed, recently launched the "Stent for Life" initiative. Its mission is to "improve the delivery and patient access to the life saving indications of percutaneous cardiovascular interventions, thereby reducing the mortality and morbidity of patients suffering from acute coronary syndromes".
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.